comparemela.com

Latest Breaking News On - Margaret kaczor william blair - Page 3 : comparemela.com

Eargo, Inc (EAR) Q1 2021 Earnings Call Transcript

Operator Ladies and gentlemen, thank you for standing by, and welcome to the Eargo first-quarter 2021 earnings conference call. [Operator instructions] As a reminder, today s conference call is being recorded. I will now turn the conference over to your host, Mr. Nick Laudico, vice president of investor relations. Sir, you may begin. Vice President of Investor Relations Good afternoon, everyone, and welcome to the Eargo first-quarter 2021 earnings conference call. The press release and slides to accompany this call are available on our investor relations website at ir.eargo.com. Please note, we have also provided supplemental historical financial information at the end of the slide presentation. As a reminder, both this live call and a digital replay will be available on our IR website.

Acutus Medical, Inc (AFIB) Q1 2021 Earnings Call Transcript

Acutus Medical, Inc. (AFIB) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Acutus Medical, Inc. (NASDAQ: AFIB) Q1 2021 Earnings Call Caroline Corner Investor Relations Thank you, operator. Welcome to Acutus s first-quarter 2021 earnings call. Joining me on today s call are Vince Burgess, president, chief executive officer; and David Roman, chief financial officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements. Factors that may cause results to differ from these forward-looking statements are discussed under the Forward-Looking Statement section in the press release attached as an exhibit to Acutus Form 8-K filed with the SEC today and are also discussed in more detail under

Inogen Inc (INGN) Q1 2021 Earnings Call Transcript

Greetings and welcome to the Inogen First Quarter 2021 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, Ali Bauerlein, Chief Financial Officer. The floor is yours. Alison Bauerlein Chief Financial Officer Thank you for participating in today s call. Joining me is CEO, Nabil Shabshab. Earlier today Inogen released financial results for the first quarter of 2021. This earnings release and Inogen s corporate presentation are currently available in the Investor Relations section of the company s website. As a reminder, the information presented today will include forward-looking statements, including without limitation statements about our growth prospects and strategy for 2021 and beyond expectations related to our operating results for 2021. Our ability to create shareholder values by driving awareness of our products, expectations regarding our international and domestic sales channels, expectations related to our rental c

Neuronetics, Inc (STIM) Q1 2021 Earnings Call Transcript

Tactile Systems Technology, Inc (TCMD) Q1 2021 Earnings Call Transcript

Operator Good evening, ladies and gentlemen, and welcome to the First Quarter of 2021 Earnings Conference Call for Tactile Medical. [Operator Instructions] At the end of the Company s prepared remarks, we will conduct a question-and-answer session. Please note that this conference call is being recorded and will be available on the Company s website for replay shortly. Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the risk factors section of our Annual Report on Form 10-K, as well as our most recent 10-Q filing, filed today with the Securities and Exchange Commission. Such factors may be updated from time to time in our filings with the SEC, which are available on our website.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.